1.      Aksentijevich I, Putnam CD, Remmers EF, et al. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum. 2007;56(4):1273-85. doi: 10.1002/art.22491

2.      Almeida de Jesus A, Goldbach-Mansky R. Monogenic autoiflammatory diseases: concept and clinical manifestations. Clin Immunol. 2013;147(3):155-74. doi: 10.1016/j.clim.2013.03.016

3.      Ammouri W, Cuisset L, Rouaghe S, et al. Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome. Rheumatology (Oxford). 2007;46(10):1597-600. doi: 10.1093/rheumatology/kem200

4.      An J, Marwaha A, Laxer RM. Autoiflammatory Diseases: A Review. J Rheumatol. 2024;51(9):848-61. doi: 10.3899/jrheum.2023-1209

5.      Blau EB. Familial granulomatous arthritis, iritis, and rash. J Pediatr. 1985;107(5):689-93. doi: 10.1016/s0022-3476(85)80394-2

6.      Booshehri LM, Hoffman HM. CAPS and NLRP3. J Clin Immunol. 2019;39(3):277-86. doi: 10.1007/s10875-019-00638-z

7.      Cetin Gedik K, Arici ZS, Kul Cinar O, et al. Practical Approach to Diagnosis and Management of IL-1-Mediated Autoiflammatory Diseases (CAPS, TRAPS, MKD, and DIRA). Paediatr Drugs. 2024;26(2):113-26. doi: 10.1007/s40272-023-00615-5

8.      Cortis E. Recurrent fever: diagnostic procedure. Italian Journal of Pediatrics. 2014;40 (Suppl 1):A25. doi: 10.1186/1824-7288-40-S1-A25

9.      Çam V, Ercan Emreol H, Ozen S. New and future perspectives in familial Mediterranean fever and other autoiflammatory diseases. Arch Rheumatol. 2024;39(3):331-8. doi: 10.46497/ArchRheumatol.2024.10911

10.  Damgaard RB, Elliott PR, Swatek KN, et al. OTULIN deficiency in ORAS causes cell type-specific LUBAC degradation, dysregulated TNF signalling and cell death. EMBO Mol Med. 2019;11(3). doi: 10.15252/emmm.201809324

11.  De Pauli S, Lega S, Pastore S, et al. Neither hereditary periodic fever nor periodic fever, aphthae, pharingitis, adenitis: Undifferentiated periodic fever in a tertiary pediatric center. World J Clin Pediatr. 2018;7(1):49-55. doi: 10.5409/wjcp.v7.i1.49

12.  Gattorno M, Hofer M, Federici S, et al. Classification criteria for autoiflammatory recurrent fevers. Ann Rheum Dis. 2019;78(8):1025-32. doi: 10.1136/annrheumdis-2019-215048

13.  Goenka A, Roderick M, Finn A, et al. The jigsaw puzzle of chronic non-bacterial osteomyelitis: are anti-IL17 therapies the next piece? Rheumatology (Oxford). 2020;59(3):459-61. doi: 10.1093/rheumatology/kez492

14.  Grandemange S, Sanchez E, Louis-Plence P, et al. A new autoiflammatory and autoimmune syndrome associated with NLRP1 mutations: NAIAD (NLRP1-associated autoenflammation with arthritis and dyskeratosis). Ann Rheum Dis. 2017;76(7):1191-8. doi: 10.1136/annrheumdis-2016-210021

15.  Haas D, Hoffmann GF. Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome. Orphanet J Rare Dis. 2006;1:13. doi: 10.1186/1750-1172-1-13

16.  Haslak F, Kilic H, Sahin S, et al. Children With Type I Interferonopathy: Commonalities and Diversities in a Large Patient Cohort. J Rheumatol. 2024;51(12):1208-17. doi: 10.3899/jrheum.2024-0294

17.  Haşlak F, Akay N, Gül Ü, et al. Autoiflammatory Bone Diseases. Balkan Med J. 2025;42(1):5-13. doi: 10.4274/balkanmedj.galenos.2024.2024-11-129

18.  Haşlak F, Kılıç Könte E, Aslan E, et al. Type I Interferonopathies in Childhood. Balkan Med J. 2023;40(3):165-74. doi: 10.4274/balkanmedj.galenos.2023.2023-4-78

19.  Hedrich CM, Morbach H, Reiser C, et al. New Insights into Adult and Paediatric Chronic Non-bacterial Osteomyelitis CNO. Curr Rheumatol Rep. 2020;22(9):52. doi: 10.1007/s11926-020-00928-1

20.  Hospach T, Glowatzki F, Blankenburg F, et al. Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents. Pediatr Rheumatol Online J. 2019;17(1):37. doi: 10.1186/s12969-019-0338-1

21.  Koryllou A, Mejbri M, Theodoropoulou K, et al. Chronic Nonbacterial Osteomyelitis in Children. Children (Basel). 2021;8(7). doi: 10.3390/children8070551

22.  Kutukculer N, Puel A, Eren Akarcan S, et al. Deficiency of Interleukin-1 Receptor Antagonist: A Case with Late Onset Severe iflammatory Arthritis, Nail Psoriasis with Onychomycosis and Well Responsive to Adalimumab Therapy. Case Reports Immunol. 2019;2019:1902817. doi: 10.1155/2019/1902817

23.  Lachmann HJ, Papa R, Gerhold K, et al. The phenotype of TNF receptor-associated autoiflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry. Ann Rheum Dis. 2014;73(12):2160-7. doi: 10.1136/annrheumdis-2013-204184

24.  Levy R, Gérard L, Kuemmerle-Deschner J, et al. Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry. Ann Rheum Dis. 2015;74(11):2043-9. doi: 10.1136/annrheumdis-2013-204991

25.  Li Y, Yu M, Lu M. Pathophysiology, clinical manifestations and current management of IL-1 mediated monogenic systemic autoiflammatory diseases, a literature review. Pediatr Rheumatol Online J. 2022;20(1):90. doi: 10.1186/s12969-022-00728-0

26.  Lina S, Ya'nan H, Ying Y, et al. Haploinsufficiency of A20 caused by a novel pathogenic missense variant of TNFAIP3 and successfully treated with anti-TNF and immunosuppressive therapies. Cell Immunol. 2023;391-392:104753. doi: 10.1016/j.cellimm.2023.104753

27.  Lordén G, Sanjuán-García I, de Pablo N, et al. Lipin-2 regulates NLRP3 enflammasome by affecting P2X7 receptor activation. J Exp Med. 2017;214(2):511-28. doi: 10.1084/jem.20161452

28.  Majeed HA, Kalaawi M, Mohanty D, et al. Congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with Sweet syndrome in two siblings. J Pediatr. 1989;115(5 Pt 1):730-4. doi: 10.1016/s0022-3476(89)80650-x

29.  McDermott MF, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoiflammatory syndromes. Cell. 1999;97(1):133-44. doi: 10.1016/s0092-8674(00)80721-7

30.  Meertens B, Hoste L, Tavernier SJ, et al. The riddle of recurrent fever: a clinical approach to pediatric autoiflammatory diseases. Front Pediatr. 2024;12:1448176. doi: 10.3389/fped.2024.1448176

31.  Milman N, Andersen CB, Hansen A, et al. Favourable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation. Apmis. 2006;114(12):912-9. doi: 10.1111/j.1600-0463.2006.apm_522.x

32.  Okorie CL, Nayudu K, Nambudiri VE. Cutaneous findings and treatments in deficiency of interleukin-36 receptor antagonist (DITRA): A review of the literature. Exp Dermatol. 2024;33(1):e14934. doi: 10.1111/exd.14934

33.  Raiji VR, Miller MM, Jung LK. Uveitis in Blau syndrome from a de novo mutation of the NOD2/CARD15 gene. J aapos. 2011;15(2):205-7. doi: 10.1016/j.jaapos.2011.02.004

34.  Rigante D, Frediani B, Cantarini L. A Comprehensive Overview of the Hereditary Periodic Fever Syndromes. Clin Rev Allergy Immunol. 2018;54(3):446-53. doi: 10.1007/s12016-016-8537-8

35.  Romano M, Arici ZS, Piskin D, et al. The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoiflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist. Ann Rheum Dis. 2022;81(7):907-21. doi: 10.1136/annrheumdis-2021-221801

36.  Rosé CD, Pans S, Casteels I, et al. Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes. Rheumatology (Oxford). 2015;54(6):1008-16. doi: 10.1093/rheumatology/keu437

37.  Schnappauf O, Aksentijevich I. Current and future advances in genetic testing in systemic autoiflammatory diseases. Rheumatology (Oxford). 2019;58(Suppl 6):vi44-vi55. doi: 10.1093/rheumatology/kez294

38.  Shen M, Tang L, Shi X, et al. NLRP12 autoiflammatory disease: a Chinese case series and literature review. Clin Rheumatol. 2017;36(7):1661-7. doi: 10.1007/s10067-016-3410-y

39.  Stych B, Dobrovolny D. Familial cold auto-iflammatory syndrome (FCAS): characterization of symptomatology and impact on patients' lives. Curr Med Res Opin. 2008;24(6):1577-82. doi: 10.1185/03007990802081543

40.  Yıldız M, Haşlak F, Adrovic A, et al. Autoiflammatory Diseases in Childhood. Balkan Med J. 2020;37(5):236-46. doi: 10.4274/balkanmedj.galenos.2020.2020.4.82